Charcot-Marie-Tooth Disease, Type 1A
8 clinical trials · Condition
◉ Watch Charcot-Marie-Tooth Disease, Type 1A
| Record | Firm | Date |
|---|---|---|
| SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study (NCT02967679) | MedDay Pharmaceuticals SA | 2016-12-05 |
| Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers (NCT02596191) | Assistance Publique Hopitaux De Marseille | 2016-06-06 |
| Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (NCT02579759) | Pharnext S.C.A. | 2015-12-01 |
| Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A) (NCT01289704) | University of Genova | 2011-02-01 |
Track Charcot-Marie-Tooth Disease, Type 1A automatically
Every clearance here is in the API, with alerts when new ones post.